ZA982188B - Compositions and methods for reducing ocular hyper-tension - Google Patents

Compositions and methods for reducing ocular hyper-tension

Info

Publication number: ZA982188B
Authority: ZA; South Africa
Prior art keywords: tension; compositions; methods; reducing ocular; hyper
Prior art date: 1997-03-17

Application number

ZA982188A

Other languages

English (en)

Inventor

Kenneth Warren Reed

Shau-Fong Yen

Mary Sou

Regina Flinn Peacock

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-03-17

Filing date

1998-03-16

Publication date

1998-09-17

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38729083&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA982188(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-03-16 Application filed by Novartis Ag filed Critical Novartis Ag

1998-09-17 Publication of ZA982188B publication Critical patent/ZA982188B/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Ophthalmology & Optometry (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

ZA982188A 1997-03-17 1998-03-16 Compositions and methods for reducing ocular hyper-tension ZA982188B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US81922197A	1997-03-17	1997-03-17

Publications (1)

Publication Number	Publication Date
ZA982188B true ZA982188B (en)	1998-09-17

Family

ID=38729083

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA982188A ZA982188B (en)	1997-03-17	1998-03-16	Compositions and methods for reducing ocular hyper-tension

Country Status (32)

Country	Link
EP (1)	EP0969846B2 (xx)
JP (2)	JP4920124B2 (xx)
KR (1)	KR100555818B1 (xx)
CN (1)	CN1236775C (xx)
AR (2)	AR002194A1 (xx)
AT (1)	ATE257385T1 (xx)
AU (1)	AU738781B2 (xx)
BR (2)	BR9808016A (xx)
CA (1)	CA2280089C (xx)
CL (1)	CL2009001870A1 (xx)
CO (1)	CO4940427A1 (xx)
CY (1)	CY2526B1 (xx)
CZ (1)	CZ299833B6 (xx)
DE (1)	DE69820997T3 (xx)
DK (1)	DK0969846T4 (xx)
EE (1)	EE04091B1 (xx)
ES (1)	ES2214706T5 (xx)
HU (1)	HU228896B1 (xx)
ID (1)	ID22389A (xx)
IL (1)	IL131041A0 (xx)
MY (1)	MY122237A (xx)
NO (1)	NO327713B1 (xx)
NZ (1)	NZ337322A (xx)
PE (1)	PE61899A1 (xx)
PL (1)	PL197509B1 (xx)
PT (1)	PT969846E (xx)
RU (1)	RU2197970C2 (xx)
SI (1)	SI0969846T2 (xx)
TW (1)	TW527187B (xx)
UA (1)	UA63938C2 (xx)
WO (1)	WO1998041208A1 (xx)
ZA (1)	ZA982188B (xx)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6011062A (en) *	1994-12-22	2000-01-04	Alcon Laboratories, Inc.	Storage-stable prostaglandin compositions
AR002194A1 (es) *	1997-03-17	1998-01-07	Sanchez Reynaldo Alemany	Instrumento computarizado para el analisis del movimiento.
US6187818B1 (en)	1998-06-17	2001-02-13	Pharmacia & Upjohn Company	Prostaglandins formulation and process
JP4880808B2 (ja) *	1999-11-15	2012-02-22	久光製薬株式会社	人工涙液型点眼剤組成物
JP4000505B2 (ja)	1999-12-01	2007-10-31	第一三共株式会社	緑内障を治療するための併用剤
CA2422031C (en) *	2000-09-13	2011-11-15	Santen Pharmaceutical Co., Ltd.	Ophthalmic solutions comprising difluoroprostaglandin f2 alpha
WO2002045748A1 (en) *	2000-12-05	2002-06-13	Sankyo Company, Limited	Ocular tension-lowering compositions for topical administration
US20020198209A1 (en) *	2001-05-03	2002-12-26	Allergan Sales Inc.	Compositions having enhanced pharmacokinetic characteristics
US7074827B2 (en)	2002-10-24	2006-07-11	Sucampo Ag (Usa) Inc.	Method for treating ocular hypertension and glaucoma
RU2266572C1 (ru) *	2004-03-17	2005-12-20	Российский государственный медицинский университет	Способ моделирования злокачественной артериальной гипертонии
CA2558135C (en) *	2004-03-18	2012-08-14	R-Tech Ueno, Ltd.	Aqueous composition comprising thiazole derivative
US8569367B2 (en) *	2004-11-16	2013-10-29	Allergan, Inc.	Ophthalmic compositions and methods for treating eyes
GB0501192D0 (en) *	2005-01-20	2005-03-02	Resolution Chemicals Ltd	Stable prostaglandin-containing compositions
US7851504B2 (en) *	2005-03-16	2010-12-14	Allergan, Inc.	Enhanced bimatoprost ophthalmic solution
DE202005005094U1 (de) *	2005-03-31	2005-07-28	Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh	Ophthalmische Zusammensetzung
EP1916002B1 (en) *	2005-08-02	2014-03-05	Santen Pharmaceutical Co., Ltd.	Method for prevention of degradation of thermally unstable substance
JP5252787B2 (ja) *	2005-08-02	2013-07-31	参天製薬株式会社	熱的に不安定な薬物の分解抑制方法
JP2007099647A (ja) *	2005-09-30	2007-04-19	Kobayashi Pharmaceut Co Ltd	粘膜適用組成物
US8168206B1 (en)	2005-10-06	2012-05-01	Allergan, Inc.	Animal protein-free pharmaceutical compositions
BRPI0708891A2 (pt) *	2006-03-13	2011-06-28	R Tech Ueno Ltd	composição aquosa
US8466174B2 (en) *	2006-03-17	2013-06-18	Johnson & Johnson Vision Care, Inc.	Methods for stabilizing oxidatively unstable compositions
JP2010508306A (ja) *	2006-10-31	2010-03-18	アルコンリサーチ，リミテッド	眼障害を治療するためのｐａｉ−１結合調節因子
WO2008096804A1 (ja) *	2007-02-07	2008-08-14	Teika Pharmaceutical Co., Ltd.	ラタノプロスト含有点眼剤
JP2009073788A (ja) *	2007-09-21	2009-04-09	Teika Seiyaku Kk	イソプロピルウノプロストン含有眼用組成物
BRPI0819081A8 (pt) *	2007-10-08	2016-08-30	Fovea Pharmaceuticals Sa	Formulação oftálmica aquosa, processo para preparar a mesma, e, método para inibir, tratar ou prevenir doenças oculares e doença ou condição relacionada, em um paciente em necessidade de tal tratamento
TWI544927B (zh)	2008-03-17	2016-08-11	愛爾康研究有限公司	具有低濃度的表面活性劑以促進治療劑之生物可利用性的藥學組成物
CN101959500A (zh) *	2008-03-17	2011-01-26	爱尔康研究有限公司	包含硼酸类化合物-多元醇络合物的水性药物组合物
EP2127638A1 (en)	2008-05-30	2009-12-02	Santen Pharmaceutical Co., Ltd	Method and composition for treating ocular hypertension and glaucoma
RU2402316C2 (ru) *	2009-01-11	2010-10-27	Пшеничников Виталий Георгиевич	Фармацевтическая антиглаукомная композиция
US8952051B2 (en) *	2009-11-05	2015-02-10	Allergan, Inc.	Ophthalmic formulations containing substituted gamma lactams and methods for use thereof
CA2830896A1 (en) *	2011-04-12	2012-10-18	Yukihiko Mashima	Aqueous ophthalmic composition
US20130029919A1 (en)	2011-07-26	2013-01-31	Allergan, Inc.	Two part formulation system for opthalmic delivery
EP2567689A1 (en)	2011-09-12	2013-03-13	Visiotact Pharma	Ophthtalmic compositions comprising prostaglandin F2 alpha derivatives and hyaluronic acid
US8957048B2 (en)	2011-10-06	2015-02-17	Allergan, Inc.	Compositions for the treatment of dry eye
SG11201403013VA (en)	2011-12-07	2014-07-30	Allergan Inc	Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
US9907826B2 (en)	2011-12-07	2018-03-06	Allergan, Inc.	Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
UA121399C2 (uk)	2014-11-25	2020-05-25	Аллерган, Інк.	Стабілізовані композиції для офтальмологічного застосування, які містять омега-3-кислоти
WO2020061550A1 (en) *	2018-09-21	2020-03-26	Aufbau Medical Innovations Limited	Compositions and methods for glaucoma
BR112021020425A2 (pt)	2019-04-12	2021-12-14	Ecolab Usa Inc	Composições de limpeza multiuso concentrada e pronta para uso, e, métodos para limpar uma superfície e de fabricação da composição de limpeza multiuso

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2059058T3 (es) *	1990-05-22	1994-11-01	R Tech Ueno Ltd	Combinacion sinergica para uso oftalmico.
IE920397A1 (en) *	1991-02-07	1992-08-12	Allergan Inc	2-decarboxyl-2-hydroxyalkyl-5-trans prostaglandin f¹derivatives
US5767154A (en) *	1991-02-07	1998-06-16	Allergan	5-trans-prostaglandins of the F series and their use as ocular hypotensives
EP0708646A1 (en) *	1994-05-06	1996-05-01	Alcon Laboratories, Inc.	Use of vitamin e tocopheryl derivatives in ophthalmic compositions
US5631287A (en) †	1994-12-22	1997-05-20	Alcon Laboratories, Inc.	Storage-stable prostaglandin compositions
US5558876A (en) *	1995-03-29	1996-09-24	Alcon Laboratories, Inc.	Topical ophthalmic acidic drug formulations
AR002194A1 (es) *	1997-03-17	1998-01-07	Sanchez Reynaldo Alemany	Instrumento computarizado para el analisis del movimiento.

1996
- 1996-06-03 AR ARP960102868A patent/AR002194A1/es unknown
1998
- 1998-03-09 MY MYPI98001017A patent/MY122237A/en unknown
- 1998-03-13 PT PT98916948T patent/PT969846E/pt unknown
- 1998-03-13 SI SI9830616T patent/SI0969846T2/sl unknown
- 1998-03-13 DE DE69820997T patent/DE69820997T3/de not_active Expired - Lifetime
- 1998-03-13 JP JP54012698A patent/JP4920124B2/ja not_active Expired - Lifetime
- 1998-03-13 BR BR9808016-4A patent/BR9808016A/pt not_active Application Discontinuation
- 1998-03-13 EE EEP199900410A patent/EE04091B1/xx not_active IP Right Cessation
- 1998-03-13 IL IL13104198A patent/IL131041A0/xx not_active IP Right Cessation
- 1998-03-13 UA UA99095110A patent/UA63938C2/uk unknown
- 1998-03-13 KR KR1019997008431A patent/KR100555818B1/ko not_active Expired - Fee Related
- 1998-03-13 PL PL335168A patent/PL197509B1/pl unknown
- 1998-03-13 CZ CZ0325799A patent/CZ299833B6/cs not_active IP Right Cessation
- 1998-03-13 PE PE1998000177A patent/PE61899A1/es not_active Application Discontinuation
- 1998-03-13 DK DK98916948.7T patent/DK0969846T4/da active
- 1998-03-13 EP EP98916948A patent/EP0969846B2/en not_active Expired - Lifetime
- 1998-03-13 HU HU0002194A patent/HU228896B1/hu not_active IP Right Cessation
- 1998-03-13 ID IDW991029A patent/ID22389A/id unknown
- 1998-03-13 AR ARP980101150A patent/AR011192A1/es not_active Application Discontinuation
- 1998-03-13 ES ES98916948T patent/ES2214706T5/es not_active Expired - Lifetime
- 1998-03-13 NZ NZ337322A patent/NZ337322A/en not_active IP Right Cessation
- 1998-03-13 BR BRPI9816218A patent/BRPI9816218B1/pt not_active IP Right Cessation
- 1998-03-13 RU RU99121641/14A patent/RU2197970C2/ru not_active IP Right Cessation
- 1998-03-13 CN CNB988030195A patent/CN1236775C/zh not_active Expired - Fee Related
- 1998-03-13 AU AU70353/98A patent/AU738781B2/en not_active Ceased
- 1998-03-13 CO CO98014184A patent/CO4940427A1/es unknown
- 1998-03-13 CA CA002280089A patent/CA2280089C/en not_active Expired - Fee Related
- 1998-03-13 WO PCT/EP1998/001483 patent/WO1998041208A1/en not_active Ceased
- 1998-03-13 AT AT98916948T patent/ATE257385T1/de active
- 1998-03-16 TW TW087103809A patent/TW527187B/zh not_active IP Right Cessation
- 1998-03-16 ZA ZA982188A patent/ZA982188B/xx unknown
1999
- 1999-09-16 NO NO19994481A patent/NO327713B1/no not_active IP Right Cessation
2005
- 2005-05-26 CY CY0500033A patent/CY2526B1/xx unknown
2009
- 2009-09-16 CL CL2009001870A patent/CL2009001870A1/es unknown
- 2009-10-09 JP JP2009235214A patent/JP2010043110A/ja active Pending

Also Published As

Publication number	Publication date
CA2280089A1 (en)	1998-09-24
ATE257385T1 (de)	2004-01-15
CZ325799A3 (cs)	2000-01-12
KR100555818B1 (ko)	2006-03-03
JP4920124B2 (ja)	2012-04-18
AU7035398A (en)	1998-10-12
NO994481L (no)	1999-09-16
EP0969846B1 (en)	2004-01-07
DK0969846T3 (da)	2004-04-13
NO327713B1 (no)	2009-09-14
AU738781B2 (en)	2001-09-27
EE9900410A (et)	2000-04-17
TW527187B (en)	2003-04-11
DK0969846T4 (da)	2010-12-20
JP2001515502A (ja)	2001-09-18
IL131041A0 (en)	2001-01-28
DE69820997T2 (de)	2004-12-09
CA2280089C (en)	2009-03-03
CN1249687A (zh)	2000-04-05
BR9808016A (pt)	2000-03-08
CN1236775C (zh)	2006-01-18
DE69820997T3 (de)	2011-10-06
CL2009001870A1 (es)	2010-01-22
NO994481D0 (no)	1999-09-16
CY2526B1 (en)	2006-02-08
RU2197970C2 (ru)	2003-02-10
ES2214706T3 (es)	2004-09-16
HK1026841A1 (en)	2000-12-29
NZ337322A (en)	2001-05-25
CO4940427A1 (es)	2000-07-24
PL335168A1 (en)	2000-04-10
SI0969846T1 (en)	2004-06-30
AR002194A1 (es)	1998-01-07
SI0969846T2 (sl)	2010-12-31
EP0969846B2 (en)	2010-08-25
MY122237A (en)	2006-04-29
PT969846E (pt)	2004-05-31
DE69820997D1 (de)	2004-02-12
HUP0002194A2 (hu)	2000-12-28
HUP0002194A3 (en)	2012-08-28
BRPI9816218B1 (pt)	2016-04-12
CZ299833B6 (cs)	2008-12-10
WO1998041208A1 (en)	1998-09-24
KR20000076330A (ko)	2000-12-26
UA63938C2 (uk)	2004-02-16
EE04091B1 (et)	2003-08-15
PL197509B1 (pl)	2008-04-30
PE61899A1 (es)	1999-06-30
ES2214706T5 (es)	2011-02-02
EP0969846A1 (en)	2000-01-12
JP2010043110A (ja)	2010-02-25
HU228896B1 (en)	2013-06-28
AR011192A1 (es)	2000-08-02
ID22389A (id)	1999-10-07

Publication	Publication Date	Title
ZA982188B (en)	1998-09-17	Compositions and methods for reducing ocular hyper-tension
HUP9900960A3 (en)	2001-02-28	Disinfecting compositions and method for disinfecting surfaces
ZA958028B (en)	1996-04-18	Compositions and methods for treatig mast-cell mediated conditions
GB9422571D0 (en)	1995-01-04	Haemorrihoidal compositions and method of use
ZA968322B (en)	1997-05-13	Solid sillicone compositions and methods for their preparation and use
ZA989400B (en)	1999-04-15	Method and composition
AU2327599A (en)	1999-08-09	Compositions and methods for treating autoimmune diseases
ZA989398B (en)	1999-04-15	Method and composition (l)
ZA964562B (en)	1996-12-12	Antipsychotic agents compositions and method of use
GB9624501D0 (en)	1997-01-15	Insecticial compositions and method
EP1139981A4 (en)	2002-04-17	COMPOSITIONS AND RELATED METHODS OF USE
AUPO982097A0 (en)	1997-11-06	Methods and compositions for use therein
GB2318356B (en)	1999-03-10	Composition and method
GB9508546D0 (en)	1995-06-14	Method and composition
AU5546298A (en)	1998-08-03	Methods and compositions for preventing autoimmune disease
AU8513698A (en)	1999-02-16	Methods and compositions for designing vaccines
AU7287798A (en)	1998-11-27	Compositions and methods for bioremediation
GB9414888D0 (en)	1994-09-14	Method and composition
GB9419087D0 (en)	1994-11-09	Method and composition
AU3423397A (en)	1998-02-26	Therapeutic methods and compositions for use therein
AU7799898A (en)	1998-12-30	Compositions and methods for treating glaucoma
AU9474898A (en)	1999-04-05	Methods and compositions for diagnosing and treating malaria
ZA961987B (en)	1996-09-26	Depressant compounds and compositions
AU4217497A (en)	1998-04-02	Skap55 compositions and methods of use therefor
GB9603471D0 (en)	1996-04-17	Therapeutic methods and compositions for use therein